Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2010
09/02/2010US20100222393 Muscarinic receptor antagonists
09/02/2010US20100222391 Benzimidazole compound crystal
09/02/2010US20100222390 Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors
09/02/2010US20100222387 3-Fluoro-Piperidine T-Type Calcium Channel Antagonists
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222374 Spirocyclic heterocyclic derivatives and methods of their use
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222365 Substituted triazole deriviatives as oxytocin antagonists
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222357 Indol-3-y-carbonyl-piperidin and piperazin-derivatives
09/02/2010US20100222353 Aminophthalazine derivative compounds
09/02/2010US20100222350 Phenyl, pyridine, quinoline, isoquinoline, naphthyridine and pyrazine derivatives
09/02/2010US20100222349 Quinoline derivatives used to treat inflammatory and allergic diseases
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222346 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
09/02/2010US20100222345 Novel compounds as antagonists or inverse agonists for opioid receptors
09/02/2010US20100222342 Pyrrolopyrazole, potent kinase inhibitors
09/02/2010US20100222341 Piperidine and piperazine derivatives
09/02/2010US20100222325 Inhibitors of Bruton's Tyrosine Kinase
09/02/2010US20100222324 Substituted Indole Compounds
09/02/2010US20100222322 Non-Nucleoside Reverse Transcriptase Inhibitors
09/02/2010US20100222319 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
09/02/2010US20100222317 Azetidine Derivatives as GlyT1 Inhibitors
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222299 Compound
09/02/2010US20100221764 Novel nitroreductase enzymatic substrates
09/02/2010US20100221327 Nanoparticulate azelnidipine formulations
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221216 Hepatitis c virus inhibitors
09/02/2010US20100221215 Linked dibenzimidazole derivatives
09/02/2010US20100221214 Linked dibenzimidazole derivatives
09/02/2010CA2759126A1 New compounds
09/02/2010CA2753434A1 Soluble guanylate cyclase activators
09/02/2010CA2752885A1 Jak kinase modulating quinazoline derivatives and methods of use thereof
09/02/2010CA2751279A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010CA2750699A1 Oxyindole derivatives with motilin receptor agonistic activity
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223919A1 Nitrogen-containing heterocyclic compound and bactericide for agricultural and horticultural use
09/01/2010EP2223912A1 Method for producing 6-halogeno-3-arylpyridine derivative
09/01/2010EP2222689A1 Compounds for therapy and diagnosis
09/01/2010EP2222664A1 Cycloalkyloxy-and het rocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor
09/01/2010EP2222663A1 A process for preparation of stable amorphous r-lansoprazole
09/01/2010EP2222662A2 Kynurenine-aminotransferase inhibitors
09/01/2010EP2222661A2 Non-nucleoside reverse transcriptase inhibitors
09/01/2010EP2222659A1 Indoles, derivatives, and analogs thereof and uses thereof
09/01/2010EP2222648A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
09/01/2010EP2222646A1 Uracil or thymine derivative for treating hepatitis c
09/01/2010EP2222639A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/01/2010EP2222638A2 Biaryl pde4 inhibitors for treating inflammation
09/01/2010EP2019825B1 Inhibitors of human immunodeficiency virus replication
09/01/2010EP2004188B1 Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor
09/01/2010EP1983987B1 Dihydrodiazepines useful as inhibitors of protein kinases
09/01/2010EP1856096B1 Phenylglycinamide derivatives useful as anticoagulants
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1838698B1 Pyrimidine derivatives as gpcr agonists
09/01/2010EP1607394B1 Water-soluble thalidomine derivatives
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010CN1976906B Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
09/01/2010CN1944425B High effective simultaneous clean extraction of high purity solanesol and nicotine
09/01/2010CN101821264A Pyridine derivatives useful as glucokinase activators
09/01/2010CN101821258A Novel preparation process
09/01/2010CN101821257A 5-HT7 receptor antagonists
09/01/2010CN101821256A Novel heterocyclic compounds as mGlu5 antagonists
09/01/2010CN101821255A 2-morpholin-4-yl-pyrimidines as PI3K inhibitors
09/01/2010CN101821254A Adrenergic compounds
09/01/2010CN101821253A Piperidine derivative
09/01/2010CN101821252A Substituted indole derivatives and methods of use thereof
09/01/2010CN101821251A Chiral cis-imidazolines
09/01/2010CN101821247A 5-(2-hydroxy phenyl)tetrazole compound as hsp90 inhibitor for anticancer
09/01/2010CN101821246A Tetrazole-substituted aryl amide derivatives and uses thereof
09/01/2010CN101821240A N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
09/01/2010CN101821237A Novel preparation process
09/01/2010CN101817815A Compounds with antibacterial activity
09/01/2010CN101817814A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
09/01/2010CN101817813A Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof
09/01/2010CN101817787A Androgen receptor antagonist for resisting prostate cancer
09/01/2010CN101817784A Ethylene derivatives and pesticides containing said derivatives
09/01/2010CN101816658A HIV inhibiting pyrimidines derivatives
09/01/2010CN101544604B Tricyclic compounds
09/01/2010CN101250182B 兰索拉唑钠 Lansoprazole sodium azole
09/01/2010CN101048399B 4-hetero aryl methyl substituted phthalazinone derivatives
08/2010
08/31/2010US7786309 Process for the preparation of esomeprazole and salts thereof
08/31/2010US7786308 ethyl 3-(4-((4-fluorophenyl)(methoxycarbonyl)amino)piperidin-1-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate; COPD, asthma, urinary incontinence, glaucoma, Alzheimer's disease; side effects reduction; selectivity for subtypes M1-M5 recptors
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease
08/31/2010US7786146 such as N-[1-(4-Trifluoromethylbenzyl)-4,6-dimethylindoline-5-yl]-3,3-dimethyl-butyramide, used as antiepileptic agents
08/31/2010US7786141 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional C5.C5N.C6 SPIRO(INDENE-2,4'-PIPERIDINE) RING structures; selective as to subtypes M1-M5
08/31/2010US7786130 Pyridones useful as inhibitors of kinases
08/31/2010US7786129 Piperazine derivatives of dialkyl oxindoles
08/31/2010US7786125 Neuroprotective small organic molecules, compositions and uses of related thereto
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786120 3-(4-(Piperidin-1-yl)styryl)-5-(2-(methylamino)pyrimidin-4-yl)pyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease
08/31/2010US7786114 protein kinase inhibitors such as 5,6-Dimethoxy-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-pyrrolo[3,2-b]pyridine, used for the treatment of cancer
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1080